Predicting dyslipidemia after liver transplantation: A significant role of recipient metabolic inflammation profile

Table 2 Comparison of post-transplant complications between post-transplant dyslipidemia and non-post-transplant dyslipidemia groups

	PTDL (n = 278)	Non-PTDL (n = 118)	P value
Acute kidney injury	69 (24.8)	27 (22.9)	0.681
Early allograft dysfunction	84 (30.2)	37 (31.4)	0.822
Portal vein stenosis	5 (1.8)	2 (1.7)	0.943
CMV infection	4 (1.4)	3 (2.5)	0.730
Bacterial infection	28 (10.1)	7 (5.9)	0.184
Diabetes mellitus	21 (7.6)	5 (4.2)	0.233
Hypertension	13 (4.7)	7 (5.9)	0.602
Cardiovascular diseases	7 (2.5)	1 (0.8)	0.490
Chronic kidney failure	3 (1.1)	0 (0)	0.681
Biliary complications	40 (14.4)	15 (12.7)	0.659
HCC recurrence1	60 (55.5)	21 (34.4)	0.008

¹In 169 HCC patients. PTDL: Post-transplant dyslipidemia; CMV: Cytomegalovirus; HCC: Hepatocellular carcinoma.